Wyniki wyszukiwania:

Targeting of the central nervous system (CNS) in order to treat disorders is actually challenging due to the necessity to cross the blood brain barrier (BBB). This review aims to show how nanomedicine can propose new approach for the treatment of CNS diseases focusing on Alzheimer's disease (AD). AD is a neurodegenerative disorder prevalent in the senile population. It is characterized by severe neuronal loss and proliferation of plaques composed of -amyloid peptide (A ) and Tau protein deposites. The absence of an effective therapeutic approach nowadays could be, in part, due to the bad...